Zacks Investment Research on MSN
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...
Johnson and Johnson stock has reached a significant milestone, achieving an all-time high of 194.5 USD. According to InvestingPro data, this price sits just below the stock’s 52-week high of $194.48, ...
Barchart on MSN
Johnson & Johnson Stock: Is Wall Street Bullish or Bearish?
Johnson & Johnson has delivered a standout performance in 2025, outperforming both the broader market and the healthcare ...
Zacks Investment Research on MSN
Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
Johnson & Johnson's latest dividend declaration translates into an annual growth rate of 4.47%. Learn more about JNJ stock here.
Johnson & Johnson’s (NYSE: JNJ) stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare ...
Johnson & Johnson posts strong Q3 2025 with robust sales, new acquisitions, and FDA approvals expanding oncology and CNS ...
Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Johnson & Johnson (NYSE:JNJ) in the last three months. The table below provides a concise ...
Key Points Jameson Private Wealth Management increased its JNJ position by 39,471 shares, with an estimated trade value of $6.76 million based on the quarter's average price The trade represents a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results